The broad US equity markets rallied to within about 1% of all-time record highs last seen in July on Tuesday as earnings season got rolling with solid beats from JP Morgan Chase (JPM), Johnson and Johnson (JNJ) and UnitedHealth Group (UNH). The world’s largest drug maker Johnson and Johnson largely shrugged off concerns about product liability legal troubles, posting strong revenue growth in several of its prescription drugs and net earnings of $2.12/share. Though thousands of lawsuits are pending because of safety issues with the prescription antipsychotic drug Risperdal as well as talc and opioids, Tuesday’s report demonstrated that JNJ’s core businesses in pharmaceuticals, consumer goods and medical devices remain strong. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Netflix, Inc. (NFLX) : Free Stock Analysis Report Coca-Cola Company (The) (KO) : Free Stock Analysis Report JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report Johnson & Johnson (JNJ) : Free Stock Analysis Report The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report Bank of America Corporation (BAC) : Free Stock Analysis Report To read this article on Zacks.com click here.
1 other references
Latest Stories From Referenced Companies
Nov 21, 2019
Nov 21, 2019